← All trials
NCT03660657
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2018
- Primary completion
- Sep 30, 2021
- Completion date
- Jan 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Dr. Negrin University HospitalLead sponsor
- Mario Negri InstituteSponsor investigator
- University of Las Palmas de Gran CanariaStudy chair
- University of Las Palmas de Gran CanariaOverall official - principal investigator
- Fundación Canaria de Investigación SanitariaCollaborator
- King Faisal Specialist HospitalOverall official - principal investigator
- Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)Collaborator
- Servicio de Evaluación. Servicio Canario de Salud. SpainCollaborator
- Servicio de Evaluación. Servicio Canario de Salud. SpainStudy director
- Servicio de Evaluación. Servicio Canario de Salud. SpainOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.